Related Experiment Video
Updated: May 6, 2026

Noninvasive Assessment of Cardiac Abnormalities in Experimental Autoimmune Myocarditis by Magnetic Resonance Microscopy Imaging in the Mouse
Published on: June 20, 2014
Inflammatory-mediated atrial cardiomyopathy diagnosed using multimodality imaging and successfully treated with
Birgitte Carbuhn Larsen1,2, Kadhem Helo Abbas Al-Badri1, Søren Mellemkjær1
1Department of Cardiology, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, 8200 Aarhus N, Denmark.
Insights
Isolated atrial cardiomyopathy, a rare condition causing atrial fibrillation and heart failure, was successfully treated with prednisolone in a patient with type 1 diabetes mellitus. This highlights the potential of anti-inflammatory therapy for managing this cardiac condition.
Area of Science:
- Cardiology
- Internal Medicine
- Inflammatory Diseases
Background:
- Atrial fibrillation (AF) is a common arrhythmia often secondary to structural heart changes.
- Atrial cardiomyopathy and heart failure (HF) can arise from AF or structural changes.
- Isolated atrial cardiomyopathy from focal atrial thickening is rare, typically linked to inflammation.
Observation:
- A patient presented with inflammatory-mediated atrial cardiomyopathy, causing AF and acute decompensated HF.
- Left atrial wall thickening was noted on transesophageal echocardiography.
- Diagnosis was confirmed via multimodality imaging and endomyocardial biopsy, with possible association to type 1 diabetes mellitus.
Findings:
- Multimodality imaging confirmed isolated atrial cardiomyopathy.
- The patient showed successful treatment response to prednisolone.
- Histology revealed no specific etiology, but type 1 diabetes mellitus was considered a potential factor.
Implications:
- Prednisolone's anti-inflammatory effects may regress atrial thickening and reduce AF occurrence.
- Early diagnosis and treatment are crucial for managing rare inflammatory atrial cardiomyopathies.
- Comprehensive imaging approaches are essential for diagnosis and monitoring treatment efficacy.
Background:
Atrial fibrillation is a common cardiac arrhythmia and often develops secondary to structural cardiac changes. Both the occurrence of atrial fibrillation and/or structural changes of the heart may lead to development of atrial cardiomyopathy and heart failure (HF). However, isolated atrial cardiomyopathy caused by focal atrial thickening is a rare condition, previously only described in case reports as a result of different aetiologies all linked to inflammation.
Case Summary:
A patient with inflammatory-mediated atrial cardiomyopathy causing atrial fibrillation and acute decompensated HF presented as isolated left atrial wall thickening on transoesophageal echocardiography. The diagnosis was confirmed using multimodality imaging with transthoracic and transoesophageal echocardiography, cardiac magnetic resonance imaging, positron emissions tomography/computer tomography scanning and intracardiac echocardiography-guided endomyocardial biopsy. Despite no specific histological aetiology, the observed atrial cardiomyopathy might be associated with type 1 diabetes mellitus. The patient in the present case was successfully treated with prednisolone.
Discussion:
Diabetes mellitus is an important risk factor for developing atrial fibrillation and diabetic cardiomyopathy, due to reduced levels of anti-inflammatory and increased levels of proinflammatory cytokines causing cardiac inflammatory structural remodelling. The regression of the atrial thickening might be due to prednisolone's anti-inflammatory effects and thereby ability to suppress atrial remodelling and reduce the occurrence of atrial fibrillation. However, the effect of prednisolone might only affect the non-manifested inflammatory-mediated atrial remodelling. Due to the rare occurrence of isolated atrial cardiomyopathy a multiple imaging approach during the diagnostic process and follow-ups are essential to determine the aetiology and effect of the treatment.
Related Concept Videos
Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis III: Medical Management
Pericarditis III: Medical Management
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy V: Interprofessional Care

